Usefulness of an in vitro-transcribed RNA control for the detection and quantification of Yellow fever virus through real-time reverse transcription-polymerase chain reaction
Introduction: Unvaccinated individuals in endemic areas with proven enzootic transmission of Yellow fever virus are at risk of infection due to a dramatic shift in the epidemiology of the disease over recent years. For this reason, epidemiological surveillance and laboratory confirmation of cases ha...
- Autores:
-
Laiton Donato, Katherine
Quintero Cortés, Paula
Franco Salazar, Juan Pablo
Peláez Carvajal, Dioselina
Navas, Maria Cristina
Junglen, Sandra
Parra Henao, Gabriel
Usme Ciro, José Aldemar
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2023
- Institución:
- Universidad Cooperativa de Colombia
- Repositorio:
- Repositorio UCC
- Idioma:
- eng
- OAI Identifier:
- oai:repository.ucc.edu.co:20.500.12494/55530
- Acceso en línea:
- https://hdl.handle.net/20.500.12494/55530
- Palabra clave:
- Yellow fever virus
RT-qPCR
Molecular detection
in vitro transcription
Plasmid DNA
- Rights
- openAccess
- License
- http://creativecommons.org/licenses/by-nc-nd/4.0/
Summary: | Introduction: Unvaccinated individuals in endemic areas with proven enzootic transmission of Yellow fever virus are at risk of infection due to a dramatic shift in the epidemiology of the disease over recent years. For this reason, epidemiological surveillance and laboratory confirmation of cases have become mandatory. Objective: To develop and test a control RNA for YFV detection through real-time RT-PCR. Methods: A 437-bp insert containing the T7 promoter and the target sequences for two different in-house protocols was designed in the context of the pUC57 vector and obtained through gene synthesis. After T7-driven in vitro transcription, standard curves were developed for Log10 serial dilutions of the YFV control RNA with 8 replicates. Results: A dynamic range of quantification of 10 orders of magnitude was observed with a limit of detection of 6.3 GCE/µL (95% CI, 2.6 to 139.4 GCE/µL). Conclusion: The plasmid construct is available for YFV molecular test validation on clinical, entomological, and epizootic samples. |
---|